Evaluation of cell surface antigens as potential targets for recombinant tumor toxins

Cancer Letters

Volumn 118, Issue 2, 1997, Pages 161-172

  Wick, Bettina ^a   Groner, Bernd ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Carbohydrate antigens; G protein coupled receptors; Tumor toxins

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CARBOHYDRATE ANTIGEN; GLYCOSPHINGOLIPID; HYBRID PROTEIN; MEMBRANE ANTIGEN; NEUROTENSIN; NEUROTENSIN RECEPTOR; PSEUDOMONAS EXOTOXIN; RECOMBINANT PROTEIN; TOXIN; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TUMOR; TUMOR CELL LINE;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIGENS, SURFACE; BACTERIAL TOXINS; CA-15-3 ANTIGEN; EXOTOXINS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTOXINS; LIGANDS; MICE; NEUROTENSIN; PROTEIN BINDING; RECEPTORS, NEUROTENSIN; RECOMBINANT PROTEINS; VIRULENCE FACTORS;

EID: 0030772734     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00327-3     Document Type: Article

References (36)

1. A.E. Frankel, D. Fitzgerald, C. Siegall, O.W. Press, Advances in immunotoxin biology and therapy: a summary of the fourth international symposium on immunotoxins, Cancer Res. 56 (1996) 926-932.
2. T. Yokata, D.E. Milenic, M. Whitlow, J. Schlom, Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms, Cancer Res. 52 (1992) 3402-3408.
3. J.B. Tatro, Z. Wen, M.L. Entwistle, M.B. Atikins, T.J. Smith, S. Reichlin, J.R. Murphy, Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma meta-stases, Cancer Res. 52 (1992) 2545-2548.
4. R.K. Puri, P.T. Mehrotra, P. Leland, R.J. Kreitman, J.P. Siegel, I. Pastan, A chimeric protein comprises of IL-4 and Pseudomonas exotoxin is cytotoxic for activated human lymphocytes, J. Immunol. 152 (1994) 3693-3700.
5. M. Jeschke, W. Wels, W. Dengler, R. Imber, E. Stöcklin, B. Groner, Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins, Int. J. Cancer 60 (1995) 730-739.
6. A.K. Singhal, Histo-blood group antigens in cancer, Semin. Cancer Biol. 2 (1991) 379-388.
7. x blood group antigens in human gastric carcinoma and in normal gastric tissue, Cancer Res. 49 (1989) 745-752.
8. S.-I. Hakamori, New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy, Cancer Cells 3 (1991) 461-470.
9. P.L. Devine, I.F.C. McKenzie, Mucins: structure, function, and associations with malignancy, BioEssays 14 (1992) 619-625.
10. J. Hilkens, Biochemistry and function of mucins in malignant disease, Cancer Rev. 11-12 (1988) 25-54.
11. M.J.L. Ligtenberg, F. Buijs, H.L. Vos, J. Hilkens, Suppression of cellular aggregation by high levels of episialin, Cancer Res. 52 (1992) 2318-2324.
12. E. Van de Wiel-van Kemenade, M.J.L. Ligtenberg, A.J. De Boer, F. Buijs, H.L. Vos, C.J.M. Melief, J. Hilkens, C.G. Figdor, Episialin (MUC 1) inhibits cytotoxic lymphocyte-target cell interaction, J. Immunol. 151 (1993) 767-776.
13. P. Pandey, S. Kharbanda, D. Kufe, Association of the DF3/ MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein, Cancer Res. 55 (1995) 4000-4003.
14. D.R. Brown, R.J. Miller, Neurotensin, Br. Med. Bull. 38 (1982) 239-245.
15. I. Zachary, P. Woll, E. Rozengurt, A role for neuropeptides in the control of cell proliferation, Dev. Biol. 124 (1987) 295-308.
16. T. Sethi, E. Rozengurt, Multiple neuropeptides stimulate clonal growth of small cell lung cancer of bradykinin, vasopressin, cholecystokinin, galanin and neurotensin, Cancer Res. 51 (1991) 3621-3623.
17. I. Sehgal, S. Powers, B. Huntley, G. Powis, M. Pittelkow, N.J. Maihle, Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer, Proc. Natl. Acad. Sci. 91 (1994) 4673-4677.
18. J. Ishizuka, C.M. Townsend, J.C. Thompson, Neurotensin regulates growth of human pancreatic cancer, Ann. Surg. 217 (1993) 439-445.
19. K. Yoshinaga, B.M. Evers, M. Izukura, D. Parekh, T. Uchida, C.M. Townsend, J.C. Thompson, Neurotensin stimulates growth of colon cancer, Surg. Oncol. 1 (1992) 127-134.
20. J.-J. Maoret, D. Pospai, C. Rouyer-Fessard, A. Couvineau, C. Laboisse, T. Voisin, M. Laburthe, Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonie epithelium: binding studies and RT-PCR experiments, Biochem. Biophys. Res. Commun. 203 (1994) 465-471.
21. J. Hwang, D.J. Fitzgerald, S. Adhya, I. Pastan, Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli, Cell 48 (1987) 129-136.
22. R. Carraway, S.E. Leeman, The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalamus, J. Biol. Chem. 248 (1973) 6854-6861.
23. J. Chabry, C. Labbé-Jullié, D. Gully, P. Kitabi, J.-P. Vincent, J. Mazella, Stable expression of the cloned rat brain neurotensin receptor in fibroblasts: binding properties, photoaffinity labeling, transduction mechanisms and internal-ization, J. Neurochem. 63 (1994) 19-27.
24. G.L. Gray, D.H. Smith, J.S. Baldridge, R.N. Harkins, M.L. Vasil, E.Y. Chen, H.L. Heyneker, Cloning, nucleotide sequence and expression in E. coli of the exotoxin A structural gene of P. aeruginosa, Proc. Natl. Acad. Sci. 81 (1984) 2645-2649.
25. W. Wels, R. Beerli, P. Hellmann, M. Schmidt, B.M. Marte, E.S. Kornilova, A. Hekele, J. Mendelsohn, B. Groner, N.E. Hynes, EGF receptor and p185 erbB-2 specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins, Int. J. Cancer 60 (1995) 137-144.
26. W. Wels, I.-M. Harwerth, M. Zwickl, N. Hardman, B. Groner, N.E. Hynes, Construction, bacterial expression and characterization of a bifunctional single-chain-antibody-phosphatase fusion protein targeted to the human erbB2-receptor, Biotechnology 10 (1992) 1128-1132.
27. P. Kitabgi, C. Poustis, C. Granier, J. Van Rietschoten, J.L. Morgat, P. Freychet, Neurotensin binding to extraneural and neural receptors: comparison with biological activity and structure-activity relationships, Mol. Pharmacol. 18 (1980) 11-19.
28. C.B. Siegall, V.K. Chaudhary, D.J. Fitzgerald, I. Pastan, Functional analysis of domains II, Ib and III of Pseudomonas exotoxin, J. Biol. Chem. 264 (1989) 14256-14261.
29. L.H. Pai, I. Pastan, Immunotoxin therapy for cancer, J. Am. Med. Assoc. 269 (1993) 78-81.
30. I. Pastan, V. Chaudhary, D.J. Fitzgerald, Recombinant toxins as novel therapeutic agents, Annu. Rev. Biochem. 61 (1992) 331-354.
31. U.C. Wargalla, R.A. Reisfeld, Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells, Proc. Natl. Acad. Sci. 86 (1989) 5146-5150.
32. C. Gottstein, U. Winkler, H. Bohlen, V. Diehl, A. Engert, Immunotoxins: is there a clinical value? Ann. Oncol. 5 (Suppl.) (1994) 97-103.
33. y immunotoxin not requiring proteolytic activation, Proc. Natl. Acad. Sci. 93 (1996) 974-978.
34. J. Calafat, C. Molthoff, H. Janssen, J. Hilkens, Endocytosis and intracellular routing of an antibody-ricin A chain conjugate, Cancer Res. 48 (1988) 3822-3827.
35. C. Granier, J. Van Rietschoten, P. Kitabgi, C. Poustis, P. Freychet, Synthesis and characterization of neurotensin analogues for structure/activity relationship studies, Eur. J. Biochem. 124 (1982) 117-125.
36. P. Bacha, J.R. Murphy, S. Reichlin, Thyrotropin-releasing hormone-diphtheria toxin-related polypeptide conjugates. Potential role of the hydrophobic domain in toxin entry, J. Biol. Chem. 258 (1983) 1565-1570.